Medical conditions that are related to diabetes, such as central obesity and high cholesterol can increase the risk of nonalcoholic fatty liver disease, and it should be noted that some medications that are used to lower cholesterol may cause liver damage. A team of researchers at Washington University School of Medicine in St. Robert H. Other medical conditions, such as obesity, high cholesterol and high blood pressure, also raise your risk of nonalcoholic fatty liver disease. The liver plays a very important role in regulating your blood sugar – when you eat, the glucose level in your blood rises and this causes your pancreas to produce insulin. NAFLD isn’t caused by booze or a nasty virus, but dietary sugar, which causes a buildup of fat in your liver. The author of the present study, Yoshio Fujitani, told Decoded Science that, from their earlier study – by scanning the human genome far and wide – they had discovered the connection between SLC30A8 mutation and zinc transport in diabetes.
However, there isn’t much evidence behind this mantra. It found that pioglitazone reduced this fatty liver disease in 58 percent of them. If you are overweight and have metabolic syndrome or diabetes, you are probably already doing your best to control your blood sugar levels by following the low-GL diet that I recommend. But really, unless you are going very severely hypo, you shouldn’t be relying on the liver to bring you round with a glucose dump. On the “production side,” it generates protein from amino acids, synthesizes steroid hormones, and forms bile acids as degradation products of cholesterol. A team of French researchers found that NAFLD is also a strong predictor of carotid atherosclerosis—that is, stiffening of the carotid artery. The liver, in my mind, is sort of a big central post office in the UK; there are letters coming in from different destinations, they go into a big sorting pile and then they go out on new pathways to new destinations.